Literature DB >> 10492139

Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

H Allgayer, P Böhne, W Kruis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492139     DOI: 10.1023/a:1026667027827

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

Review 1.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

2.  Pathogenesis of intestinal strictures in Crohn's disease-an update.

Authors:  M F Graham
Journal:  Inflamm Bowel Dis       Date:  1995       Impact factor: 5.325

Review 3.  Review article: the medical management of Crohn's disease.

Authors:  E Elton; S B Hanauer
Journal:  Aliment Pharmacol Ther       Date:  1996-02       Impact factor: 8.171

4.  Comparative and experimental pathology of fibrosing colonopathy.

Authors:  D van Velzen; L M Ball; A R Dezfulian; A Southgate; C V Howard
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

5.  Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.

Authors:  H Allgayer; K Deschryver; W F Stenson
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

6.  High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

Authors:  S C FitzSimmons; G A Burkhart; D Borowitz; R J Grand; T Hammerstrom; P R Durie; J D Lloyd-Still; A B Lowenfels
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

7.  Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis.

Authors:  M Mourelle; F Guarner; J R Malagelada
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

  7 in total
  1 in total

1.  Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

Authors:  Marie T Bakowski; Philip Prescott
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.